Association of variants in estrogen-related pathway genes with prostate cancer risk. - Wikidata - wikimedia - TriplyDB

Association of variants in estrogen-related pathway genes with prostate cancer risk.

Association of variants in estrogen-related pathway genes with prostate cancer risk.

http://www.wikidata.org/entity/Q30532192

about

Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk.Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length.The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies

P2860

Q33792655-291D891E-485A-43DC-94DE-8824D5CEBCB9 Q34493813-FAC7CD67-8E79-4840-982B-7C87B0C45ABC Q34827929-4B84A58C-B25B-4F5A-BA0D-47E487B9F8B8 Q37327993-E2A9A069-FA48-4CE2-8815-1A060B80B090 Q38409787-CFD252E5-6A17-4318-B04C-95A86F9D143F Q38620751-CDDF0C88-1C1E-41D2-A2ED-4FDCCD9DE438 Q38627269-80103F81-6407-46EC-ADEA-866F8456E0E1 Q41727091-567DD597-C3D6-4C07-93F3-A410701DD3A4 Q42364927-E24DD3F7-33D4-463D-8493-621F3574731B Q46314579-96B38DA1-2824-4544-948B-F20FA2EF87CD Q46725795-C4327AA1-8CCA-44BF-B82E-E10D8298C778 Q47692316-D183DD50-A7C5-4EF1-8B89-83077BAED2BC Q49520171-27AA1CC5-DF1F-4F98-9F75-77532CF6C4DF Q53134756-96C59DD8-1AD9-4ACD-8435-B29B359063AC Q57174165-52486373-0C1C-4F44-8884-448E6ADBBF69

P2860

Association of variants in estrogen-related pathway genes with prostate cancer risk.

http://www.wikidata.org/entity/Q30532192

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@ast

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@en

type

label

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@ast

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@en

prefLabel

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@ast

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@en

P1433

Q30532192-8CFEA89D-0527-4435-9367-D0ECC7DE21C5

P1476

Q30532192-F5F90160-73F5-4FC6-AFDE-EA0B8423E3B6

P2093

Q30532192-22831EE5-9BAF-4719-A683-1892C5E81E98

Q30532192-6902BD3B-D491-490C-83F6-ED587DF5BB91

Q30532192-725A8BD4-9B2B-41CF-9ABE-01553DCF6A95

Q30532192-D2422AC2-5017-4E66-A83C-01CD6A015DFA

Q30532192-D785E17C-1F03-4759-B109-436CE166D670

Q30532192-E8DA430E-C71B-44C4-9270-8DC1D9BA14C7

P2860

Q30532192-02D928A5-AA8B-402E-9A5F-FDA9CF6E4937

Q30532192-044A3B88-BB03-4F32-B2C7-772766267D79

Q30532192-3F060D51-965A-4FE5-9E5E-7C452023B9F6

Q30532192-42DAEAF8-9103-47E1-A341-3E0AD3A26C09

Q30532192-433DA9C7-554E-4A40-9188-4982BE6B4A99

Q30532192-52051281-455A-4410-A4E9-A9FF5A207001

Q30532192-6C3BBC23-DF98-4DC5-871C-3335345BEC94

Q30532192-7268BB74-9A79-400A-B685-0D421002C4B3

Q30532192-7B3742DC-A654-4BCC-91B5-E840FE971678

Q30532192-86B2AC67-A302-47AD-8BD6-4DACBD75002F

P304

Q30532192-F56DEDD2-9520-4969-9C92-68D3DD2FFB96

P31

Q30532192-9A050FCB-88BF-48B4-8075-6D2017E8EB6C

P356

Q30532192-AD1EC68A-8907-4106-9680-8F4B357C94CF

P433

Q30532192-FC350DC7-A3A5-459D-8D5C-E27ACCA5BF81

P478

Q30532192-BC54B4A6-2AA7-4798-A2B3-FAF5AB5409AD

P50

Q30532192-BB1F33D9-EF07-48C6-B9AB-0006C0885FEF

P577

Q30532192-90BEF98F-3079-46B0-8C06-E8F420EDB468

P698

Q30532192-13EC24AC-7540-489B-8BF4-119F663E4183

P932

Q30532192-BDF4AA34-10D8-4E3D-A0DD-0AAE5C86E210

P356

P1433

P1476

Association of variants in estrogen-related pathway genes with prostate cancer risk.

@en

P2093

Erika M Kwon

http://www.w3.org/2001/XMLSchema#string

Janet L Stanford

http://www.w3.org/2001/XMLSchema#string

Rong Fu

http://www.w3.org/2001/XMLSchema#string

Sarah K Holt

http://www.w3.org/2001/XMLSchema#string

Suzanne Kolb

http://www.w3.org/2001/XMLSchema#string

Ziding Feng

http://www.w3.org/2001/XMLSchema#string

P2860

PLINK: a tool set for whole-genome association and population-based linkage analyses

Haploview: analysis and visualization of LD and haplotype maps

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.

Endogenous estrogens as carcinogens through metabolic activation.

Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms.

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.22534

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Elaine Ostrander

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22549291

http://www.w3.org/2001/XMLSchema#string

P932

3544476

http://www.w3.org/2001/XMLSchema#string